Pesquisar
Caris Life Sciences Inc
CAIAdicionar à lista de desejos
14.562USD
-0.688-4.51%
Horário de mercado （ET）Cotações atrasadas em 15 min
4.11BValor de mercado
PerdaP/L TTM
Mais detalhes de Caris Life Sciences Inc Empresa
Caris Life Sciences Inc. is a patient-centric, next-generation artificial intelligence tech bio company and precision medicine provider. The Company develops and commercializes solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale. Its entire portfolio of precision medicine solutions is designed to benefit patients, with an initial focus on oncology, and serves the clinical, academic, and biopharma markets. Its platform is purpose-built to leverage the convergence of next-generation sequencing (NGS), artificial intelligence (AI) and machine learning (ML) technologies, and high-performance computing. Its purpose-built, proprietary multi-omic profiling solutions capture and analyze molecular information from tissue and blood in a comprehensive manner. Its services for biopharma companies include prospective and retrospective profiling services, and companion diagnostics development.
Informações de Caris Life Sciences Inc
Código da empresaCAI
Nome da EmpresaCaris Life Sciences Inc
Data de listagemJun 18, 2025
CEOHalbert (David Dean)
Número de funcionários- -
Tipo de títulosOrdinary Share
Fim do ano fiscalJun 18
Endereço750 W. John Carpenter Freeway
CidadeIRVING
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal75039
Telefone18667718946
Sitehttps://www.carislifesciences.com/
Código da empresaCAI
Data de listagemJun 18, 2025
CEOHalbert (David Dean)
Executivos da empresa Caris Life Sciences Inc
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. George H. Poste, Ph.D.
Dr. George H. Poste, Ph.D.
Vice Chairman of the Board
Vice Chairman of the Board
511.70K
--
Mr. Luke Power
Mr. Luke Power
Chief Financial Officer, Senior Vice President, Chief Accounting Officer
Chief Financial Officer, Senior Vice President, Chief Accounting Officer
163.54K
+39.12%
Mr. David (Dave) Fredrickson
Mr. David (Dave) Fredrickson
Independent Director
Independent Director
2.49K
--
Mr. David Dean Halbert
Mr. David Dean Halbert
Chairman of the Board, Chief Executive Officer, Founder
Chairman of the Board, Chief Executive Officer, Founder
--
--
Dr. Jonathan Knowles, Ph.D.
Dr. Jonathan Knowles, Ph.D.
Vice Chairman of the Board
Vice Chairman of the Board
--
--
Mr. Brian J. Brille
Mr. Brian J. Brille
Vice Chairman of the Board, Executive Vice President
Vice Chairman of the Board, Executive Vice President
--
--
Dr. David Spetzler, Ph.D.
Dr. David Spetzler, Ph.D.
President
President
--
--
Mr. Nathan Burns
Mr. Nathan Burns
Independent Director
Independent Director
--
--
Mr. Peter M. Castleman
Mr. Peter M. Castleman
Lead Independent Director
Lead Independent Director
--
--
Mr. Joseph E. Gilliam
Mr. Joseph E. Gilliam
Independent Director
Independent Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. George H. Poste, Ph.D.
Dr. George H. Poste, Ph.D.
Vice Chairman of the Board
Vice Chairman of the Board
511.70K
--
Mr. Luke Power
Mr. Luke Power
Chief Financial Officer, Senior Vice President, Chief Accounting Officer
Chief Financial Officer, Senior Vice President, Chief Accounting Officer
163.54K
+39.12%
Mr. David (Dave) Fredrickson
Mr. David (Dave) Fredrickson
Independent Director
Independent Director
2.49K
--
Mr. David Dean Halbert
Mr. David Dean Halbert
Chairman of the Board, Chief Executive Officer, Founder
Chairman of the Board, Chief Executive Officer, Founder
--
--
Dr. Jonathan Knowles, Ph.D.
Dr. Jonathan Knowles, Ph.D.
Vice Chairman of the Board
Vice Chairman of the Board
--
--
Mr. Brian J. Brille
Mr. Brian J. Brille
Vice Chairman of the Board, Executive Vice President
Vice Chairman of the Board, Executive Vice President
--
--
Detalhamento da receita
Moeda: USDAtualizado em: seg, 6 de abr
Moeda: USDAtualizado em: seg, 6 de abr
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
Os dados relevantes ainda não foram divulgados pela empresa.
Por RegiãoUSD
Nome
Receita
Proporção
United States
801.39M
98.69%
International
10.64M
1.31%
Por Empresa
Por Região
Os dados relevantes ainda não foram divulgados pela empresa.
Distribuição de ações
Atualizado em: qui, 14 de mai
Atualizado em: qui, 14 de mai
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Halbert (David D)
43.52%
Sixth Street Partners, LLC
6.86%
J.H. Whitney Capital Partners, LLC
6.46%
J. H. Whitney Equity Partners VI, LLC
6.46%
Fidelity Management & Research Company LLC
4.48%
Outro
32.23%
Investidores
Investidores
Proporção
Halbert (David D)
43.52%
Sixth Street Partners, LLC
6.86%
J.H. Whitney Capital Partners, LLC
6.46%
J. H. Whitney Equity Partners VI, LLC
6.46%
Fidelity Management & Research Company LLC
4.48%
Outro
32.23%
Tipos de investidores
Investidores
Proporção
Individual Investor
48.53%
Investment Advisor
26.42%
Hedge Fund
13.90%
Private Equity
7.96%
Investment Advisor/Hedge Fund
5.69%
Research Firm
0.93%
Pension Fund
0.60%
Sovereign Wealth Fund
0.04%
Bank and Trust
0.03%
Participação acionária institucional
Atualizado em: qua, 1 de abr
Atualizado em: qua, 1 de abr
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2026Q4
228
134.49M
38.87%
--
2026Q1
348
157.12M
55.58%
+16.76M
2025Q4
261
137.01M
48.56%
+26.69M
2025Q3
172
130.04M
46.09%
+127.36M
2025Q2
45
192.42M
69.23%
+189.87M
2025Q1
3
2.55M
0.92%
+2.55M
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Halbert (David D)
123.08M
43.56%
+320.11K
+0.26%
Mar 06, 2026
Sixth Street Partners, LLC
19.39M
6.86%
-5.00M
-20.50%
Dec 31, 2025
J.H. Whitney Capital Partners, LLC
20.26M
7.17%
--
--
Dec 31, 2025
Fidelity Management & Research Company LLC
12.67M
4.48%
+3.09M
+32.26%
Dec 31, 2025
Castleman Peter M
10.38M
3.67%
+5.51K
+0.05%
Feb 26, 2026
Coatue Management, L.L.C.
9.82M
3.48%
-322.21K
-3.18%
Dec 31, 2025
T. Rowe Price Investment Management, Inc.
9.21M
3.26%
+1.18M
+14.71%
Dec 31, 2025
Braidwell LP
7.82M
2.77%
+500.00K
+6.83%
Dec 31, 2025
PointState Capital LP
6.72M
2.38%
+2.83M
+73.00%
Dec 31, 2025
Ver Mais
ETFs Relacionados
Atualizado em: sáb, 6 de dez
Atualizado em: sáb, 6 de dez
Nome
Proporção
ARK Genomic Revolution ETF
0.67%
Texas Capital Texas Small Cap Equity Index ETF
0.52%
Renaissance IPO ETF
0.43%
RiverNorth Patriot ETF
0.3%
Franklin Genomic Advancements ETF
0.29%
Invesco Russell 1000 Equal Weight ETF
0.08%
Inspire 500 ETF
0.07%
T Rowe Price Small-Mid Cap ETF
0.05%
Texas Capital Texas Equity Index ETF
0.04%
Fidelity Nasdaq Composite Index ETF
0.02%
Ver Mais
ARK Genomic Revolution ETF
Proporção0.67%
Texas Capital Texas Small Cap Equity Index ETF
Proporção0.52%
Renaissance IPO ETF
Proporção0.43%
RiverNorth Patriot ETF
Proporção0.3%
Franklin Genomic Advancements ETF
Proporção0.29%
Invesco Russell 1000 Equal Weight ETF
Proporção0.08%
Inspire 500 ETF
Proporção0.07%
T Rowe Price Small-Mid Cap ETF
Proporção0.05%
Texas Capital Texas Equity Index ETF
Proporção0.04%
Fidelity Nasdaq Composite Index ETF
Proporção0.02%
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Data ex-dividendo
Tipo
Proporção
Sem dados
Data
Data ex-dividendo
Tipo
Proporção
Sem dados
